p65 Negatively regulates transcription of the cyclin E gene

Vaibhao C Janbandhu1, Anup K Singh, Atish Mukherji

  • 1Virology Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India.

Insights

Nuclear factor-kappa B (NF-kappaB) acts as a cell cycle brake. This study shows NF-kappaB represses cyclin E gene transcription, leading to cell cycle arrest at G1/S phase.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Nuclear factor-kappa B (NF-kappaB) is crucial for cellular functions, including cell cycle regulation.
  • NF-kappaB activates cyclin D1 and p21(Waf1) genes, suggesting a role in cell cycle modulation.

Purpose of the Study:

  • To investigate the role of NF-kappaB in G1/S phase regulation.
  • To identify NF-kappaB's transcriptional targets involved in cell cycle progression.

Main Methods:

  • Overexpression of NF-kappaB and induction by tumor necrosis factor-alpha.
  • Monitoring transcriptional regulators and gene expression.
  • Chromatin immunoprecipitation and PCR-based assays to analyze promoter binding and chromatin structure.

Main Results:

  • Cyclin E gene identified as a key transcriptional target of NF-kappaB.
  • NF-kappaB recruitment to the cyclin E promoter correlated with gene transrepression.
  • NF-kappaB induction led to decreased cyclin E transcription, inactive cyclin E-cdk2 complexes, and G1/S phase arrest.

Conclusions:

  • NF-kappaB acts as a negative regulator of the cell cycle.
  • Transcriptional repression of cyclin E by NF-kappaB is a mechanism for cell cycle arrest.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...